Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sabina A. Islam, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R01AI121248 (ISLAM, SABINA A) Nov 21, 2016 - Oct 31, 2021
    NIH
    Modulation of Chronic Th2 inflammation by the CCR8 Receptor-Ligand Pathway
    Role: Principal Investigator
  2. R56AI101348 (ISLAM, SABINA A) Jul 20, 2014 - Jun 30, 2016
    NIH
    Modulation of chronic Th2 inflammation by the CCR8 receptor-ligand pathway
    Role: Principal Investigator
  3. K08AI055663 (ISLAM, SABINA A) Sep 30, 2003 - Jul 31, 2009
    NIH
    Role of the BLTR1 receptor in lymphocyte trafficking
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Borges TJ, Abarzua P, Gassen RB, Kollar B, Lima-Filho M, Aoyama BT, Gluhova D, Clark RA, Islam SA, Pomahac B, Murphy GF, Lian CG, Talbot SG, Riella LV. T cell-attracting CCL18 chemokine is a dominant rejection signal during limb transplantation. Cell Rep Med. 2022 03 15; 3(3):100559. PMID: 35492875; PMCID: PMC9040185.
    Citations: 2     Fields:    Translation:Humans
  2. Cho JL, Ling MF, Adams DC, Faustino L, Islam SA, Afshar R, Griffith JW, Harris RS, Ng A, Radicioni G, Ford AA, Han AK, Xavier R, Kwok WW, Boucher R, Moon JJ, Hamilos DL, Kesimer M, Suter MJ, Medoff BD, Luster AD. Allergic asthma is distinguished by sensitivity of allergen-specific CD4+ T cells and airway structural cells to type 2 inflammation. Sci Transl Med. 2016 10 05; 8(359):359ra132. PMID: 27708065; PMCID: PMC5399547.
    Citations: 22     Fields:    Translation:HumansCells
  3. Severa M, Islam SA, Waggoner SN, Jiang Z, Kim ND, Ryan G, Kurt-Jones E, Charo I, Caffrey DR, Boyartchuk VL, Luster AD, Fitzgerald KA. The transcriptional repressor BLIMP1 curbs host defenses by suppressing expression of the chemokine CCL8. J Immunol. 2014 Mar 01; 192(5):2291-304. PMID: 24477914; PMCID: PMC3943885.
    Citations: 18     Fields:    Translation:AnimalsCells
  4. Islam SA, Ling MF, Leung J, Shreffler WG, Luster AD. Identification of human CCR8 as a CCL18 receptor. J Exp Med. 2013 Sep 23; 210(10):1889-98. PMID: 23999500.
    Citations: 77     Fields:    Translation:HumansAnimalsCells
  5. Islam SA, Luster AD. T cell homing to epithelial barriers in allergic disease. Nat Med. 2012 May 04; 18(5):705-15. PMID: 22561834; PMCID: PMC3863331.
    Citations: 99     Fields:    Translation:HumansAnimalsCells
  6. Islam SA, Chang DS, Colvin RA, Byrne MH, McCully ML, Moser B, Lira SA, Charo IF, Luster AD. Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells. Nat Immunol. 2011 Feb; 12(2):167-77. PMID: 21217759.
    Citations: 128     Fields:    Translation:HumansAnimalsCells
  7. Khan IA, Thomas SY, Moretto MM, Lee FS, Islam SA, Combe C, Schwartzman JD, Luster AD. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog. 2006 Jun; 2(6):e49. PMID: 16789839; PMCID: PMC1475660.
    Citations: 71     Fields:    Translation:AnimalsCells
  8. Islam SA, Thomas SY, Hess C, Medoff BD, Means TK, Brander C, Lilly CM, Tager AM, Luster AD. The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans. Blood. 2006 Jan 15; 107(2):444-53. PMID: 16179368; PMCID: PMC1490027.
    Citations: 25     Fields:    Translation:HumansCells
  9. Medoff BD, Seung E, Wain JC, Means TK, Campanella GS, Islam SA, Thomas SY, Ginns LC, Grabie N, Lichtman AH, Tager AM, Luster AD. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J Exp Med. 2005 Jul 04; 202(1):97-110. PMID: 15998790; PMCID: PMC2212891.
    Citations: 28     Fields:    Translation:HumansAnimalsCells
  10. Tager AM, Bromley SK, Medoff BD, Islam SA, Bercury SD, Friedrich EB, Carafone AD, Gerszten RE, Luster AD. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol. 2003 Oct; 4(10):982-90. PMID: 12949531.
    Citations: 127     Fields:    Translation:AnimalsCells
  11. Meyer-Olson D, Brady KW, Blackard JT, Allen TM, Islam S, Shoukry NH, Hartman K, Walker CM, Kalams SA. Analysis of the TCR beta variable gene repertoire in chimpanzees: identification of functional homologs to human pseudogenes. J Immunol. 2003 Apr 15; 170(8):4161-9. PMID: 12682248.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  12. Cohen GB, Islam SA, Noble MS, Lau C, Brander C, Altfeld MA, Rosenberg ES, Schmitz JE, Cameron TO, Kalams SA. Clonotype tracking of TCR repertoires during chronic virus infections. Virology. 2002 Dec 20; 304(2):474-84. PMID: 12504586.
    Citations: 18     Fields:    Translation:HumansCells
  13. Cameron TO, Cohen GB, Islam SA, Stern LJ. Examination of the highly diverse CD4(+) T-cell repertoire directed against an influenza peptide: a step towards TCR proteomics. Immunogenetics. 2002 Dec; 54(9):611-20. PMID: 12466894.
    Citations: 10     Fields:    Translation:HumansCells
  14. Altfeld M, Addo MM, Eldridge RL, Yu XG, Thomas S, Khatri A, Strick D, Phillips MN, Cohen GB, Islam SA, Kalams SA, Brander C, Goulder PJ, Rosenberg ES, Walker BD. Vpr is preferentially targeted by CTL during HIV-1 infection. J Immunol. 2001 Sep 01; 167(5):2743-52. PMID: 11509618.
    Citations: 39     Fields:    Translation:HumansCells
  15. Islam SA, Hay CM, Hartman KE, He S, Shea AK, Trocha AK, Dynan MJ, Reshamwala N, Buchbinder SP, Basgoz NO, Kalams SA. Persistence of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte clones in a subject with rapid disease progression. J Virol. 2001 May; 75(10):4907-11. PMID: 11312363; PMCID: PMC114246.
    Citations: 12     Fields:    Translation:HumansCells
  16. Wainberg MA, Drosopoulos WC, Salomon H, Hsu M, Borkow G, Parniak M, Gu Z, Song Q, Manne J, Islam S, Castriota G, Prasad VR. Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Science. 1996 Mar 01; 271(5253):1282-5. PMID: 8638110.
    Citations: 105     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Islam's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (152)
Explore
_
Co-Authors (25)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.